Your browser doesn't support javascript.
loading
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Ohnishi, Tetsuo; Balan, Shabeesh; Toyoshima, Manabu; Maekawa, Motoko; Ohba, Hisako; Watanabe, Akiko; Iwayama, Yoshimi; Fujita, Yuko; Tan, Yunfei; Hisano, Yasuko; Shimamoto-Mitsuyama, Chie; Nozaki, Yayoi; Esaki, Kayoko; Nagaoka, Atsuko; Matsumoto, Junya; Hino, Mizuki; Mataga, Nobuko; Hayashi-Takagi, Akiko; Hashimoto, Kenji; Kunii, Yasuto; Kakita, Akiyoshi; Yabe, Hirooki; Yoshikawa, Takeo.
Affiliation
  • Ohnishi T; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Balan S; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Toyoshima M; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Maekawa M; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Ohba H; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Watanabe A; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Iwayama Y; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan; Support Unit for Bio-Material Analysis, Research Resources Division, RIKEN Center for Brain Science, Saitama, Japan.
  • Fujita Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
  • Tan Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
  • Hisano Y; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Shimamoto-Mitsuyama C; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Nozaki Y; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Esaki K; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan.
  • Nagaoka A; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Matsumoto J; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Hino M; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Mataga N; Support Unit for Bio-Material Analysis, Research Resources Division, RIKEN Center for Brain Science, Saitama, Japan.
  • Hayashi-Takagi A; Laboratory of Medical Neuroscience, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan.
  • Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
  • Kunii Y; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan; Department of Psychiatry, Aizu Medical Center, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Kakita A; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Yabe H; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Yoshikawa T; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan. Electronic address: takeo.yoshikawa@riken.jp.
EBioMedicine ; 45: 432-446, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31255657
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotropic Drugs / Schizophrenia / Betaine / Choline Dehydrogenase Type of study: Prognostic_studies Limits: Animals / Humans / Male Country/Region as subject: Asia Language: En Journal: EBioMedicine Year: 2019 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotropic Drugs / Schizophrenia / Betaine / Choline Dehydrogenase Type of study: Prognostic_studies Limits: Animals / Humans / Male Country/Region as subject: Asia Language: En Journal: EBioMedicine Year: 2019 Document type: Article Affiliation country: Japan